Litcius/Paper detail

LBA7 Neoadjuvant immune checkpoint inhibition in locally advanced MMR-deficient colon cancer: The NICHE-2 study

Myriam Chalabi, Y.L. Verschoor, J. van den Berg, Karolina Sikorska, Geerard L. Beets, Anja van Lent, M.C. Grootscholten, A. Aalbers, N. Buller, Hendrik A. Marsman, Eduard R. Hendriks, Pim Burger, T. Aukema, Steven J. Oosterling, Regina G. H. Beets‐Tan, Ton N. Schumacher, Monique E. van Leerdam, E.E. Voest, J.B.A.G. Haanen

2022Annals of Oncology191 citationsDOIOpen Access PDF

Topics & Concepts

MedicineIpilimumabNivolumabInternal medicineOncologyPopulationClinical endpointColorectal cancerNeoadjuvant therapyAdjuvantCancerSurrogate endpointStage (stratigraphy)ImmunotherapyGastroenterologySurgeryClinical trialBreast cancerBiologyEnvironmental healthPaleontologyColorectal and Anal CarcinomasCancer Immunotherapy and BiomarkersColorectal Cancer Treatments and Studies